Treatment of 22q11.2 deletion syndrome-associated schizophrenia with comorbid anxiety and panic disorder
22q11.2 deletion syndrome (22q11DS) is a risk factor for psychiatric illnesses, including schizophrenia and anxiety. Small studies have shown that several neuroleptic medications are effective in treating psychosis in this population, but are also associated with an increased risk of adverse effects...
Saved in:
Main Authors: | Candace B. Borders, Amanda Suzuki, David Safani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-10-01
|
Series: | Mental Illness |
Subjects: | |
Online Access: | http://www.pagepress.org/journals/index.php/mi/article/view/7225 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systemic lupus erythematosus in a patient with 22q11.2 deletion syndrome: A case report and review of the literature
by: Chen Sun, et al.
Published: (2024-11-01) -
Characteristics of velopharyngeal dysfunction in 22q11.2 deletion syndrome: a retrospective case-control study
by: Sebastiano Failla, et al.
Published: (2020-07-01) -
Development of Speech and Communication in Polish Children with 22q11.2 Deletion Syndrome: A Cross-Sectional Study
by: Natalia Moćko, et al.
Published: (2024-12-01) -
Driving Innovation to Support Pupils with SEND Through Co-Production in Education and Research: Participatory Action Research with 22q11.2 Deletion Syndrome Families in England
by: Michelle Jayman, et al.
Published: (2024-12-01) -
Somatic copy number deletion of chromosome 22q in papillary thyroid carcinoma
by: Olivia W Lee, et al.
Published: (2025-01-01)